USC Norris Oncology Hematology Newport Beach — Newport Beach, California

Public research footprint of USC Norris Oncology Hematology Newport Beach, compiled from the ClinicalTrials.gov public registry.

101

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Metastatic Bladder Urothelial Carcinoma · Locally Advanced Ureter Urothelial Carcinoma · Lung Non-Squamous Non-Small Cell Carcinoma · B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1

Recently updated registry entries

NCT06203600 — Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal… (Recruiting)
NCT05198830 — Testing the Addition of an Anti-Cancer Drug, TRC102, to the Usual Chemotherapy Treatment… (Recruiting)
NCT05987241 — Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at USC Norris Oncology Hematology Newport Beach?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 06, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.